Literature DB >> 23405959

Refractory migraine - a review.

Elliott Schulman1.   

Abstract

Refractory migraine has long been a challenge to all headache specialists. This subgroup of migraine patients experience disability and impaired quality of life, despite optimal treatment. This article reviews the proposed definitions and epidemiology of refractory migraine, as well as the pathophysiology that may contribute to the genesis of this disorder. Aspects of treatment, including pharmacological, complementary/adjunct, and invasive approaches, are reviewed. Comorbid factors, medication overuse, potential pitfalls to treatment, and areas for future investigation are highlighted.
© 2013 American Headache Society.

Entities:  

Mesh:

Year:  2013        PMID: 23405959     DOI: 10.1111/head.12047

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

1.  Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A?

Authors:  Calogera Butera; Bruno Colombo; Francesca Bianchi; Marco Cursi; Roberta Messina; Stefano Amadio; Roberta Guerriero; Giancarlo Comi; Ubaldo Del Carro
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

2.  P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience.

Authors:  Filippo Baldacci; Martina Cafalli; Cinzia Lucchesi; Sonia Mazzucchi; Elisa Dini; Ubaldo Bonuccelli; Sara Gori
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

Review 3.  Emerging therapies for chronic migraine.

Authors:  Alberto Proietti Cecchini; Licia Grazzi
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 4.  What Constitutes an "Adequate" Trial in Migraine Prevention?

Authors:  Jonathan H Smith; Todd J Schwedt
Journal:  Curr Pain Headache Rep       Date:  2015-11

Review 5.  Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity.

Authors:  Eric S Schwenk; Basant Pradhan; Rohit Nalamasu; Lucas Stolle; Irving W Wainer; Michael Cirullo; Alexander Olsen; Joseph V Pergolizzi; Marc C Torjman; Eugene R Viscusi
Journal:  Curr Pain Headache Rep       Date:  2021-07-16

6.  Chronic Migraine Preventive Treatment by Prefrontal-Occipital Transcranial Direct Current Stimulation (tDCS): A Proof-of-Concept Study on the Effect of Psychiatric Comorbidities.

Authors:  Giulio Mastria; Alessandro Viganò; Alessandra Corrado; Valentina Mancini; Cristina Pirillo; Simone Badini; Barbara Petolicchio; Massimiliano Toscano; Marta Altieri; Roberto Delle Chiaie; Vittorio Di Piero
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

7.  Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis.

Authors:  Eric S Schwenk; Marc C Torjman; Ruin Moaddel; Jacqueline Lovett; Daniel Katz; William Denk; Clinton Lauritsen; Stephen D Silberstein; Irving W Wainer
Journal:  J Clin Pharmacol       Date:  2021-07-09       Impact factor: 2.860

8.  Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation.

Authors:  Francesca Puledda; Peter J Goadsby; Prab Prabhakar
Journal:  J Headache Pain       Date:  2018-01-16       Impact factor: 7.277

9.  Polypharmacy Among Headache Patients: A Cross-Sectional Study.

Authors:  Anna Ferrari; Carlo Baraldi; Manuela Licata; Cecilia Rustichelli
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

10.  Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study.

Authors:  Tomor Harnod; Cheng-Li Lin; Chia-Hung Kao
Journal:  J Clin Med       Date:  2018-09-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.